The Lundquist Institute Elevates Keith Hoffman to Senior Vice President of Business Development and Technology Transfer

Longtime business development executive to oversee incubator facilities and biotech park planning

LOS ANGELES – The Lundquist Institute, formerly the Los Angeles Biomedical Research Institute (LA BioMed), has promoted Keith Bronson Hoffman, PhD to Senior Vice President of Business Development and Technology Transfer.

PTSD After Wildfires Can Be Reduced with Early Triage Technology

The Lundquist Institute research offers lessons for communities from California to Australia

LOS ANGELES — An investigator from The Lundquist Institute has demonstrated a way to limit the effects of post-traumatic stress disorder in those affected by wildfires through early intervention and triage using a web-based app, providing valuable insight for medical professionals and first responders dealing with the aftermath of another devastating fire season.

Cocaine Use Compounds HIV-Related Memory Loss, Study Finds

Abstaining from cocaine use can help HIV-positive people with cognition 

LOS ANGELES — A new study from The Lundquist Institute shows that cocaine use exacerbates memory loss and other neuropsychological impairments among people with HIV, providing new insight into the effects of cocaine and more information to better treat HIV-positive individuals. 

Implementation Science Reduces Unnecessary Antibiotic Use in the ER

New study from The Lundquist Institute can help stop the spread of superbugs

LOS ANGELES — A new study from The Lundquist Institute shows a reliable, repeatable way to reduce the unnecessary use of antibiotics in emergency departments and urgent care centers. Overusing antibiotics does not help patients, wastes money, and more importantly is accelerating the epidemic of drug-resistant bacteria—or “superbugs.”

Ketamine Is an Effective Treatment for Chronic Pain

Study from The Lundquist Institute finds sub-dissociative doses useful for acute flare-ups

LOS ANGELES — A study from The Lundquist Institute shows that modest doses of ketamine can effectively treat acute exacerbations of chronic pain, providing physicians with another proven option aside from addictive opioids, which have devastated communities and resulted in thousands of early deaths in recent years.